Bharat Biotech, SII arm Bilthoven Biologicals collaborate to produce, supply Oral polio vaccine Ruchika Sharma3 April 2024 1:30 PM ISTThrough this collaboration, BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India...
Serum Institute looks beyond COVID with new vaccines for malaria, dengue Roshni Dhar12 March 2024 5:49 PM ISTThe CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the...
Health Bulletin 12/ March/2024 Roshni Dhar12 March 2024 5:01 PM ISTHere are the top health news for the day:Reevaluating Intensivist Criteria: Doctors' urgent appealUpset with the definition of an 'Intensivist'...
SII looks beyond coronavirus with new vaccines for dengue, malaria Ruchika Sharma11 March 2024 12:29 PM ISTPoonawalla said Serum has capacity to manufacture 100 million doses of its malaria vaccine, and could scale up further depending on demand.
WHO prequalifies SII Multivalent meningococcal meningitis vaccine Ruchika Sharma13 July 2023 2:10 PM ISTMenFive is approved by WHO for use in individuals 1 through 85 years of age and will initially be available for use in reactive vaccine campaigns for...
Delete defamatory content against Serum Institute of India: Bombay HC directs two individuals Ruchika Sharma6 Jun 2023 12:35 PM ISTThe suit said the defendants had also been posting incorrect information that implied the Covishield vaccine was the cause of deaths of multiple...
Serum Institute has produced five to six million Covovax doses: Adar Poonawalla Ruchika Sharma24 April 2023 1:30 PM ISTCovovax is the only COVID vaccine made in India which is approved in the US and Europe. Currently, the demand is very small, Poonawalla said.
Rise in COVID cases: Serum Institute restarts manufacturing of Covishield Ruchika Sharma13 April 2023 2:15 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid...
SII cervical cancer vaccine to be available in market this month at Rs 2000 for two doses Roshni Dhar10 Feb 2023 6:00 PM ISTThe Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per...
Health Bulletin 10/February/2023 Roshni Dhar10 Feb 2023 4:44 PM ISTHere are the top health stories for the day:NMC gives deadline to FMGE June 2023 candidates applying for eligibility certificateReferring to the...
Serum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for two doses: Sources Ruchika Sharma10 Feb 2023 12:15 PM ISTNew Delhi: The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of...
China needs good COVID booster vaccine like Covovax, but they haven't given positive response: Serum Institute CEO Adar Poonawalla Ruchika Sharma29 Jan 2023 12:45 PM ISTAs per sources, NTAGI is likely to soon meet regarding the inclusion of COVID vaccine Covovax on the CoWIN portal as heterologous booster dose for...
